Breast Medical Oncologist at MDAnderson. Vice President Clinical Research. Tweets and opinions are my own.
Joined April 2013
- Tweets459
- Following947
- Followers1.7K
- Likes1.8K
@skopetz @MDAndersonNews . starting the scientific portion of research townhall on cancer evolution. Tune in!
Jennifer Litton retweeted
Huge congratulations to our incredible mentor, Dr. Mariana Chavez MacGregor, on being named @MDAndersonNews Mentor of the Year! I’m greatly appreciative of your guidance, unwavering support and sponsorship. So well deserved! ✨
Jennifer Litton retweeted
Thanks to a generous $150 million gift from Kinder Foundation, we announce the launch of Kinder Children’s Cancer Center. This joint venture of UT MD Anderson and @TexasChildrens has a single mission: to #EndChildhoodCancer. brnw.ch/21wSEOo #UTMDAnderson_TexasChildrens
Jennifer Litton retweeted
To all SITC members - election starts May 2 and I would strongly encourage consideration of Dr. Tina Cascone as a dynamic and visionary physician scientist and translational researcher. A true pioneer and leader in the lung cancer space. @sitcancer
sitcancer.org/membership/202…
Congratulations Tim
We are pleased to announce that Timothy A. Yap, MBBS, PhD, of The University of Texas MD Anderson Cancer Center, has been appointed Editor-in-Chief of Clinical Cancer Research. Learn More: brnw.ch/21wQV12
Jennifer Litton retweeted
We’re days out from the ice storm that will impact blood supply @MDAndersonNews. Take 30 minutes this weekend (or during a half day on Monday) to make a difference by donating blood for our cancer patients. Make an appointment at MDAndersonBloodBank.org. #EndCancer
Great case discussions from our GU team reviewing adjuvant pembro this morning. And remembering Chris Wood. @MDAndersonNews
Jennifer Litton retweeted
Hear Ye! Hear Ye! The AACR Annual Election is here! Vote for the man, the myth for AACR Board of Directors!
Jennifer Litton retweeted
Looking forward to this ALL STAR Jim Allison Institute symposium on #Immunotherapy in Space and Time at @MDAndersonNews tomorrow.
mdanderson.org/research/rese…
Jennifer Litton retweeted
Starting tomorrow, MD Anderson experts will present the latest advances in cancer care at the European Society for Medical Oncology Congress.
Read highlights from presentations and details about onsite opportunities: MDAnderson.org/ESMO @myESMO #ESMO24 #EndCancer
ALT Graphic reads, "MD Anderson at ESMO".
Jennifer Litton retweeted
Thank you to the SITC breast cancer CPG expert panel for their contributions. @DrGattiMays @JenniferLitton @DrNDisis @KalinskyKevin @hmcarthur @RitaNandaMD @hoperugo @stolaney1
Jennifer Litton retweeted
Our Dr. Jason Westin shares insights on how CAR-T therapy could improve first-line therapy in some lymphoma patients: bit.ly/3VXzPNv @Lymphoma_Doc #EndCancer
Jennifer Litton retweeted
It was an honor to be part of the plenary session — especially to celebrate progress for patients with lung cancer and be with wonder colleagues. #LCSM
“ADRIATIC is the first positive global Phase III trial of immunotherapy for limited stage small cell #LungCancer,” says our Dr. @LaurenByersMD at #ASCO24. “This groundbreaking trial sets a new standard of care with consolidative durvalumab following concurrent chemoradiotherapy.” @ASCO #EndCancer
ALT Dr. Lauren Byers at #ASCO24
Jennifer Litton retweeted
At #ASCO24? Be sure to stop by the @MDAndersonNews booth (#13069) for our Meet the Experts sessions and to grab a coffee. Find out more info at MDAnderson.org/ASCO. #EndCancer
KOPETZ!!!!!
The antibody drug conjugate M9140 demonstrates promising activity in heavily pretreated patients with advanced #ColorectalCancer.
Read about the findings presented by our Dr. Scott Kopetz (Abstract 3000) at #ASCO24: bit.ly/4bHkgzc @skopetz @ASCO #EndCancer
ALT Dr. Scott Kopetz at #ASCO24
Jennifer Litton retweeted
Congratulations, Dr. Hunt. We are proud to have you on our team and are grateful for your commitment to #EndCancer. @KellyKhunt
Congratulations to @KellyKhunt on your induction into @OncLive's 12th Annual Giants of Cancer Care recognition program! Recognizing your contributions to breast cancer research and patient care @MDAndersonNews #OncSurgery #EndCancer
Jennifer Litton retweeted
Drugs that got accelerated approval may be the only option for patients with rare or advanced cancers, says our Dr. Jennifer Litton. “It’s important for doctors to carefully explain the evidence.”
Learn more: brnw.ch/21wID60 @AP @JenniferLitton #EndCancer
Jennifer Litton retweeted
Cervical cancer kills 300,000 people a year — here’s how to speed up its elimination nature.com/articles/d41586-0… – at Houston, TX